Cisplatin pretreatment enhances the antitumor activity of cytokine-induced killer cells in a T cell-dependent manner

Huang Xiang,Huang Guichun,Song Haizhu,Chen yitian,Chen Longbang
DOI: https://doi.org/10.3969/j.issn.1672-1535.2011.06.010
2011-01-01
Abstract:Objective To investigate the antitumor activity of cytokine-induced killer(CIK) cells following cisplatin(DDP) pretreatment in a murine CT-26 colon adenocarcinoma model and to elucidate the underlying mechanisms mediating the immunomodulating effect of DDP precondition.Methods BALB/c wild type and BALB/c nu/nu mice were challenged with CT-26 cells to establish colon adenocarcinoma modesl and then randomly divided into 4 groups.Control group: treated with normal saline(NS);CIK group: administered with CIK cells;DDP group: administered with DDP;DDP-CIK group: administered with DDP followed by CIK cells.Tumor size and weight were used as indicators of therapeutic response.Immunohistochemistry was performed to observe the intratumoral infiltration of CD3+ T lymphocytes and FoxP3+ regulatory T(Treg) cells and tumor microvessel density.The dynamic changes of Treg cells in spleen tissues after DDP preconditioning chemotherapy were analyzed through flow cytometry.Results In CT-26 colon adenocarcinoma models,CIK cell therapy alone or DDP alone markedly inhibited the growth of CT-26 colon adenocarcinoma in BALB/c wild type mice(P <0.05),and the combination of DDP preconditioning chemotherapy and CIK cells induced significant tumor growth retardation compared with single therapy(P<0.05).However,in BALB/c nu/nu mice,the combination therapy and both of the single therapies failed to induce significant tumor growth inhibition(P>0.05).DDP preconditioning chemotherapy in CT-26 colon adenocarcinoma model increased the level of T lymphocytes in local tumor tissues,decreased the percentages of Treg cells in tumor and spleen tissues,but exerted no influence on tumor microvessel density.Conclusion DDP preconditioning chemotherapy can enhance the antitumor activity of CIK cell therapy in CT-26 colon carcinoma mice.
What problem does this paper attempt to address?